PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsCTI Biopharma
CTI Biopharma(CTIC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
VonjoPacritinib2022-02-282028-2030
Primary myelofibrosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pacritinib
healthy volunteers/patients
,
drug interactions
,
myeloid leukemia acute
,
myeloid leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia acute
,
leukemia myeloid chronic atypical bcr-abl negative
,
myelomonocytic leukemia juvenile
,
syndrome
,
renal insufficiency
,
liver diseases
,
hepatic insufficiency
,
leukemia
,
myelodysplastic syndromes
,
myeloproliferative disorders
,
preleukemia
,
neoplasms
,
graft vs host disease
,
t-cell lymphoma
,
lymphoproliferative disorders
,
covid-19
,
colorectal neoplasms
,
hematologic diseases
,
bone marrow diseases
,
primary myelofibrosis
,
polycythemia vera
,
essential thrombocythemia
,
thrombocytosis
,
polycythemia
,
thrombocytopenia
TOSEDOSTAT
neoplasms
,
healthy volunteers/patients
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
neoplasm metastasis
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
multiple myeloma
,
plasma cell neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use